Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
28 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/28/3089259/0/en/Alvotech-and-Advanz-Pharma-Extend-Strategic-Partnership-to-Commercialize-Three-Additional-Biosimilars-in-Europe.html
03 Dec 2024
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/after-temporary-reprieve-intercepts-liver-med-ocaliva-loses-marketing-nod-europe
27 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/27/2988006/0/en/ADVANZ-PHARMA-s-response-to-the-reversal-of-the-suspension-of-the-European-Commission-decision-on-the-OCALIVA-conditional-marketing-authorisation-in-Europe.html
04 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/04/2973886/0/en/European-Medicines-Agency-Confirms-Acceptance-of-Marketing-Authorization-Application-for-AVT05-a-Proposed-Biosimilar-to-Simponi-golimumab.html
05 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/05/2941050/0/en/ADVANZ-PHARMA-secures-temporary-suspension-of-the-European-Commission-decision-on-the-OCALIVA-conditional-marketing-authorisation-in-Europe.html
03 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/03/2939357/0/en/ADVANZ-PHARMA-s-response-to-European-Commission-revocation-of-conditional-marketing-authorisation-for-OCALIVA-in-rare-disease-Primary-Biliary-Cholangitis-PBC.html
ABOUT THIS PAGE